Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VBI-S for Hypotension in Hypovolemic Septic Shock
NCT04257136Phase 2Active, not recruiting
- Sponsor
- Vivacelle Bio
- Start
- Feb 2020
- Primary completion
- Dec 2023
- Modality
- Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of VBI-S in septic shock, sponsored by Vivacelle Bio. Started Feb 2020; status: active, not recruiting.
02
Drugs
VBI-S
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT04257136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04257136.